Not all SNPs identified by genome-wide association studies (GWAS) are functional in disease pathogenesis.

the verdict

SUPPORTED

the evidence backs this

Recorded sources

4 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that not all SNPs identified by genome-wide association studies (GWAS) are functional in disease pathogenesis?

Yes. Genome-wide association studies (GWAS) routinely identify statistical risk variants, but many reside in non-coding regions or act as markers rather than causal elements, requiring downstream functional annotation and multi-omics analysis to confirm their biological roles.

Verdict: SUPPORTED · 4 sources for, 0 against · Last checked 4 Oct 2026

Evidence for · 4

miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease

2016

Identifies specific functional polymorphisms within Alzheimer's disease GWAS loci that impact miRNA-mediated gene expression.

Get citation

Delay, C., Grenier-Boley, B., Amouyel, P., Dumont, J., & Lambert, J. (2016). miRNA-dependent target regulation: functional characterization of single-nucleotide polymorphisms identified in genome-wide association studies of Alzheimer’s disease. doi.org. https://doi.org/10.1186/s13195-016-0186-x

See more details

More for · 3

Functional Annotation of Alzheimer's Disease-Associated SNPs Based on Three-Dimensional Chromatin Structure.

2026

Notes that many GWAS loci reside in non-coding regions and require integrative computational frameworks to identify true effector genes.

Get citation

H, L., Z, W., X, L., & X, S. (2026). Functional Annotation of Alzheimer's Disease-Associated SNPs Based on Three-Dimensional Chromatin Structure.. doi.org. https://doi.org/10.3390/ijms27188396

Integrative post-GWAS analysis prioritizes immune regulatory pathways and candidate effector signals in systemic lupus erythematosus.

2026

Highlights the challenge of translating polygenic GWAS signals into functionally validated candidate genes and regulatory mechanisms in SLE.

Get citation

V, M., M, K., N, P., SL, S., P, L., & A, S. (2026). Integrative post-GWAS analysis prioritizes immune regulatory pathways and candidate effector signals in systemic lupus erythematosus.. doi.org. https://doi.org/10.1016/j.jtauto.2026.100399

Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes.

2026

Explains that most primary open-angle glaucoma risk loci from GWAS reside in non-coding regions with unclear function, requiring multi-omics mapping.

Get citation

J, G., Y, Y., H, L., Y, N., X, L., J, L., S, L., Y, Q., M, B., X, S., Z, Z., D, P., H, W., AP, K., M, H., Y, H., & H, Z. (2026). Decoding Primary Open-Angle Glaucoma: A Multi-Omics Approach to Identify Druggable Effector Genes.. doi.org. https://doi.org/10.1167/iovs.67.11.19

Receipt History

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work